Apple Makes Another Big Splash in Healthcare – Sangamo Stock’s Cancer Opportunity

Pfizer pulls sickle cell treatment Oxbryta off global markets

Pfizer said Wednesday that it was removing Oxbryta, a pill for the treatment of sickle cell disease, from all markets globally due to high risks

September 25, 2024

War zone or not, Ukraine seeks to reclaim its role as a hub for clinical trials

In the years leading up to Russia’s invasion, Ukraine had become a burgeoning hub of clinical trials, particularly in oncology. The war put a hold

February 22, 2024

Monte Rosa’s $100M offering; Alexion to hand back preclinical program to Zealand Pharma

Plus, news about First Wave BioPharma: Monte Rosa’s $100M offering: The molecular glue degrader biotech priced the offering at $4.70 per share $GLUE and expects

May 17, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.